Clinical Trials Browser

Unknown × aldesleukin × Lymphoid × Clear all

NCT03778619 2020-07-28

MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

NCT00006100 2013-12-18

Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma

Phase 1 Unknown

Hodgkin Disease, Lymphoma